Osseointegration Implants Market, By Product (Dental Implants, Knee Implants, Hip Implants, Spinal Implants, and Others), By Material (Ceramics, Zirconia, Titanium, Stainless Steel, and Others), By End User (Hospitals, Ambulatory Surgical Centers, Dental Clinics, and Others), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa)

Published In : Nov 2024

Code : CMI2384

Pages :153

Formats :

Excel and PDF

Industry : Medical Devices

Key Developments

On February 7, 2024, ZimVie Inc., a global leader in life sciences within the dental and spine sectors, announced the launch of TSX Implant in Japan. Designed for immediate extraction and standard loading protocols, TSX Implants offer placement predictability and primary stability in both soft and dense bone.
In October 2023, Amber Implants, a medical technology company, announced the initiation of a clinical trial for VCFix Spinal System implant aimed at patients suffering from vertebral compression fractures. The implant comes with a user-friendly, single-use sterile surgical kit, ensuring complete traceability and minimizing the risk of infection.
In July 2023, Parkview Regional Medical Center, a nonprofit short-term acute care facility, and Orthopaedics NorthEast (ONE), a leading orthopedic practice in Indiana, U.S., launched an osseointegration program in partnership with Integrum, the manufacturer of the OPRA Implant System. This initiative aims to provide innovative solutions for patients needing limb prosthetics, enhancing their mobility and quality of life through advanced surgical techniques.
In December 2022, New York University, a private research institution, completed its initial surgeries using the only FDA-approved implantable prosthetic for individuals with limb loss available in the greater New York City area. The procedure, known as osseointegration, aims to enhance the quality of life for those with limb loss by improving the connection between the limb and the prosthesis.